The Hypothalamic Glucagon-Like Peptide 1 Receptor Is Sufficient but Not Necessary for the Regulation of Energy Balance and Glucose Homeostasis in Mice
Open accessThe DOI matches its Crossref record; 50 of the 51 references it cites were found in a registry or an index.
Abstract
Pharmacological activation of the hypothalamic glucagon-like peptide 1 (GLP-1) receptor (GLP-1R) promotes weight loss and improves glucose tolerance. This demonstrates that the hypothalamic GLP-1R is sufficient but does not show whether it is necessary for the effects of exogenous GLP-1R agonists (GLP-1RA) or endogenous GLP-1 on these parameters. To address this, we crossed mice harboring floxed Glp1r alleles to mice expressing Nkx2.1-Cre to knock down Glp1r expression throughout the hypothalamus (GLP-1RKDΔNkx2.1cre). We also generated mice lacking Glp1r expression specifically in two GLP-1RA–responsive hypothalamic feeding nuclei/cell types, the paraventricular nucleus (GLP-1RKDΔSim1cre) and proopiomelanocortin neurons (GLP-1RKDΔPOMCcre). Chow-fed GLP-1RKDΔNkx2.1cre mice exhibited increased food intake and energy expenditure with no net effect on body weight. When fed a high-fat diet, these mice exhibited normal food intake but elevated energy expenditure, yielding reduced weight gain. None of these phenotypes were observed in GLP-1RKDΔSim1cre and GLP-1RKDΔPOMCcre mice. The acute anorectic and glucose tolerance effects of peripherally dosed GLP-1RA exendin-4 and liraglutide were preserved in all mouse lines. Chronic liraglutide treatment reduced body weight in chow-fed GLP-1RKDΔNkx2.1cre mice, but this effect was attenuated with high-fat diet feeding. In sum, classic homeostatic control regions are sufficient but not individually necessary for the effects of GLP-1RA on nutrient homeostasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“our data suggest that key drug-accessible GLP1R populations outside of the hindbrain (including vagal afferents and the hypothalamus45) are dispensable for their therapeutic effects”
From Dissociable hindbrain GLP1R circuits for satiety and aversion (2024) · cites this paper as [45]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biology of Incretins: GLP-1 and GIP
Baggio, L. L., & Drucker, D. J. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.054 · Cited by 3,639 · cited 1×
“Glucagon-like peptide 1 (GLP-1) is a gut-secreted peptide that augments glucose-dependent insulin secretion via a pancreatic GLP-1 receptor (GLP-1R) (1).”
BackgroundSelf-citationA role for glucagon-like peptide-1 in the central regulation of feeding
Turton, M. D., O'Shea, D., Gunn, I., Beak, S. A., Edwards, C. M. B., Meeran, K., Choi, S. J., Taylor, G. M., Heath, M. M., Lambert, P. D., et al. (1996) · Nature · doi:10.1038/379069a0 · Cited by 1,950
Divergence of Melanocortin Pathways in the Control of Food Intake and Energy Expenditure
Balthasar, N., Dalgaard, L. T., Lee, C. E., Yu, J., Funahashi, H., Williams, T., Ferreira, M., Tang, V., McGovern, R. A., Kenny, C. D., et al. (2005) · Cell · doi:10.1016/j.cell.2005.08.035 · Cited by 1,120
The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss
Secher, A., Jelsing, J., Baquero, A. F., Hecksher-Sørensen, J., Cowley, M. A., Dalbøge, L. S., Hansen, G., Grove, K. L., Pyke, C., Raun, K., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci75276 · Cited by 961
Leptin receptor signaling in POMC neurons is required for normal body weight homeostasis
Balthasar, N., Coppari, R., McMinn, J., Liu, S. M., Lee, C. E., Tang, V., Kenny, C. D., McGovern, R. A., Chua, S. C., Elmquist, J. K., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.06.004 · Cited by 935
GLP-1 agonism stimulates brown adipose tissue thermogenesis and browning through hypothalamic AMPK
Beiroa, D., Imbernon, M., Gallego, R., Senra, A., Herranz, D., Villarroya, F., Serrano, M., Fernø, J., Salvador, J., Escalada, J., et al. (2014) · Diabetes · doi:10.2337/db14-0302 · Cited by 602 · cited 4×
“This is surprising because ICV or hypothalamic administration of GLP-1RA increases EE (15,43).”
BackgroundMethodInfluentialCentral administration of GLP-1-(7-36) amide inhibits food and water intake in rats
Tang-Christensen, M., Larsen, P. J., Goke, R., Fink-Jensen, A., Jessop, D. S., Moller, M., & Sheikh, S. P. (1996) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1996.271.4.r848 · Cited by 597
Interactions of Glucagon-Like Peptide-1 (GLP-1) with the Blood-Brain Barrier
Kastin, A. J., Akerstrom, V., & Pan, W. (2002) · Journal of Molecular Neuroscience · doi:10.1385/jmn:18:1-2:07 · Cited by 480
Yamamoto, H., Lee, C. E., Marcus, J., Williams, T. D., Overton, J. M., Lopez, M. E., Hollenberg, A. N., Baggio, L. L., Saper, C. B., Drucker, D. J., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15595 · Cited by 473
Self-citationYamamoto, H., Lee, C. E., Marcus, J. N., Williams, T. D., Overton, J. M., Lopez, M. E., Hollenberg, A. N., Baggio, L., Saper, C. B., Drucker, D. J., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215595 · Cited by 429
Self-citation
Cited by
Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1
Drucker, D. J. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.03.001 · Cited by 2,170
“Burmeister et al. (2017) used Nkx2.”
BackgroundInfluentialSelf-citationChait, A., & den Hartigh, L. J. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.00022 · Cited by 1,529
The Discovery and Development of Liraglutide and Semaglutide
Knudsen, L. B., & Lau, J. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00155 · Cited by 970
Semaglutide lowers body weight in rodents via distributed neural pathways.
Gabery, S., Salinas, C. G., Paulsen, S. J., Ahnfelt-Rønne, J., Alanentalo, T., Baquero, A. F., Buckley, S. T., Farkas, E., Fekete, C., Frederiksen, K. S., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.133429 · Cited by 717
“Furthermore, the efficacy of liraglutide is not altered by area postrema (AP) or PVH ablation or by vagal lesions (8, 20).”
BackgroundGLP-1 physiology informs the pharmacotherapy of obesity
Drucker, D. J. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101351 · Cited by 510
Self-citationRevisiting the Complexity of GLP-1 Action from Sites of Synthesis to Receptor Activation
McLean, B. A., Wong, C. K., Campbell, J. E., Hodson, D. J., Trapp, S., & Drucker, D. J. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnaa032 · Cited by 289
Self-citationArea postrema cell types that mediate nausea-associated behaviors
Zhang, C., Kaye, J. A., Cai, Z., Wang, Y., Prescott, S. L., & Liberles, S. D. (2021) · Neuron · doi:10.1016/j.neuron.2020.11.010 · Cited by 263
HypoMap—a unified single-cell gene expression atlas of the murine hypothalamus
Steuernagel, L., Lam, B. Y. H., Klemm, P., Dowsett, G. K. C., Bauder, C. A., Tadross, J. A., Hitschfeld, T. S., del Rio Martin, A., Chen, W., de Solis, A. J., et al. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00657-y · Cited by 267
Enterochromaffin 5-HT cells – A major target for GLP-1 and gut microbial metabolites
Lund, M. L., Egerod, K. L., Engelstoft, M. S., Dmytriyeva, O., Theodorsson, E., Patel, B. A., & Schwartz, T. W. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.03.004 · Cited by 254
Beyond the pancreas: contrasting cardiometabolic actions of GIP and GLP1
Hammoud, R., & Drucker, D. J. (2023) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00783-3 · Cited by 244
“Consistent with these findings, selective targeting of GLP1R + neurons in the hypothalamus or hindbrain does not completely attenuate the weight-reducing actions of GLP1RAs in mice or rats 151,152 .”
Self-citationThe Role of GLP-1 in the Metabolic Success of Bariatric Surgery
Hutch, C. R., & Sandoval, D. (2017) · Endocrinology · doi:10.1210/en.2017-00564 · Cited by 236
Self-citationAnti-obesity therapy: from rainbow pills to polyagonists
Müller, T. D., Clemmensen, C., Finan, B., DiMarchi, R. D., & Tschöp, M. H. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014803 · Cited by 199
An inter-organ neural circuit for appetite suppression
Zhang, T., Perkins, M. H., Chang, H., Han, W., & de Araujo, I. E. (2022) · Cell · doi:10.1016/j.cell.2022.05.007 · Cited by 192
GLP-1: Molecular mechanisms and outcomes of a complex signaling system
Smith, N. K., Hackett, T. A., Galli, A., & Flynn, C. R. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.04.010 · Cited by 188
Liu, J., Conde, K., Zhang, P., Lilascharoen, V., Xu, Z., Lim, B. K., Seeley, R. J., Zhu, J. J., Scott, M. M., & Pang, Z. P. (2017) · Neuron · doi:10.1016/j.neuron.2017.09.042 · Cited by 190
Self-citationSignalling from the periphery to the brain that regulates energy homeostasis
Kim, K.-S., Seeley, R. J., & Sandoval, D. A. (2018) · Nature Reviews Neuroscience · doi:10.1038/nrn.2018.8 · Cited by 183
Self-citationGlucagon-like Peptide-1 Receptor-based Therapeutics for Metabolic Liver Disease
Yabut, J. M., & Drucker, D. J. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnac018 · Cited by 175
Self-citationTimper, K., del Río-Martín, A., Cremer, A. L., Bremser, S., Alber, J., Giavalisco, P., Varela, L., Heilinger, C., Nolte, H., Trifunovic, A., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.05.001 · Cited by 170
Role of Bile Acids and GLP-1 in Mediating the Metabolic Improvements of Bariatric Surgery
Albaugh, V. L., Banan, B., Antoun, J., Xiong, Y., Guo, Y., Ping, J., Alikhan, M., Clements, B. A., Abumrad, N. N., & Flynn, C. R. (2019) · Gastroenterology · doi:10.1053/j.gastro.2018.11.017 · Cited by 173
Dissociable hindbrain GLP1R circuits for satiety and aversion
Huang, K.-P., Acosta, A. A., Ghidewon, M. Y., McKnight, A. D., Almeida, M. S., Nyema, N. T., Hanchak, N. D., Patel, N., Gbenou, Y. S. K., Adriaenssens, A. E., et al. (2024) · Nature · doi:10.1038/s41586-024-07685-6 · Cited by 166
“Rather, our data indicate that key drug-accessible GLP1R populations outside the hindbrain (including vagal afferents and the hypothalamus 45 ) are dispensable for their therapeutic effects, a notion that is supported by earlier work in decerebrate rats 46 .”
Adams, J. M., Pei, H., Sandoval, D. A., Seeley, R. J., Chang, R. B., Liberles, S. D., & Olson, D. P. (2018) · Diabetes · doi:10.2337/db17-1385 · Cited by 159
“In rats, intracerebroventricular injection of a specific GLP-1R antagonist, exendin(9-39) has been shown to increase food intake in the short and long term, suggesting that neuronal GLP-1Rs contribute to normal feeding behavior (43,44).”
BackgroundSelf-citationIepsen, E. W., Zhang, J., Thomsen, H. S., Hansen, E. L., Hollensted, M., Madsbad, S., Hansen, T., Holst, J. J., Holm, J.-C., & Torekov, S. S. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.05.008 · Cited by 156
Li, C., Navarrete, J., Liang-Guallpa, J., Lu, C., Funderburk, S. C., Chang, R. B., Liberles, S. D., Olson, D. P., & Krashes, M. J. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2018.10.016 · Cited by 145
He, Z., Gao, Y., Lieu, L., Afrin, S., Cao, J., Michael, N. J., Dong, Y., Sun, J., Guo, H., & Williams, K. W. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.07.008 · Cited by 128
“Moreover, GLP-1 receptors in POMC neurons are required for weight regulation on a High fat diet (HFD) [30].”
BackgroundFortin, S. M., Lipsky, R. K., Lhamo, R., Chen, J., Kim, E., Borner, T., Schmidt, H. D., & Hayes, M. R. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aay8071 · Cited by 127
“Further supporting an extrahypothalamic model for GLP-1R’s anorectic effects are decerebrate rat studies demonstrating a normal reduction in food intake following peripheral GLP-1R agonists (14) and studies that fail to observe hypothalamic neuronal activation following peripheral GLP-1R agonist administration (42, 49…”
BackgroundInfluentialKabahizi, A., Wallace, B., Lieu, L., Chau, D., Dong, Y., Hwang, E., & Williams, K. W. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15682 · Cited by 126
Hindbrain circuits in the control of eating behaviour and energy balance
Cheng, W., Gordian, D., Ludwig, M. Q., Pers, T. H., Seeley, R. J., & Myers, M. G. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00606-9 · Cited by 134
Self-citationThe autonomic nervous system and cardiac GLP-1 receptors control heart rate in mice
Baggio, L. L., Ussher, J. R., McLean, B. A., Cao, X., Kabir, M. G., Mulvihill, E. E., Mighiu, A. S., Zhang, H., Ludwig, A., Seeley, R. J., et al. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.08.010 · Cited by 117
Self-citationGut hormone polyagonists for the treatment of type 2 diabetes
Brandt, S. J., Götz, A., Tschöp, M. H., & Müller, T. D. (2018) · Peptides · doi:10.1016/j.peptides.2017.12.021 · Cited by 111
Mechanisms controlling hormone secretion in human gut and its relevance to metabolism
Martin, A. M., Sun, E. W., & Keating, D. J. (2020) · Journal of Endocrinology · doi:10.1530/joe-19-0399 · Cited by 109
Molecular aspects of diabetes mellitus: Resistin, microRNA, and exosome
Saeedi Borujeni, M. J., Esfandiary, E., Taheripak, G., Codoñer‐Franch, P., Alonso‐Iglesias, E., & Mirzaei, H. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26271 · Cited by 106
Varin, E. M., Mulvihill, E. E., Baggio, L. L., Koehler, J. A., Cao, X., Seeley, R. J., & Drucker, D. J. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.05.055 · Cited by 104
“A combination of pharmacological studies, optogenetics, chemogenetics, cell ablation, and cell-specific knockdown of the GLP-1R within the CNS implicates multiple neural GLP-1R circuits in the control of food intake, reward, and body weight (Adams et al., 2018; Burmeister et al., 2017; Hayes et al., 2011; Holt et al.,…”
BackgroundResultSelf-citationSingh, I., Wang, L., Xia, B., Liu, J., Tahiri, A., El Ouaamari, A., Wheeler, M. B., & Pang, Z. P. (2022) · Cell & Bioscience · doi:10.1186/s13578-022-00914-3 · Cited by 98
Loss of dorsomedial hypothalamic GLP-1 signaling reduces BAT thermogenesis and increases adiposity
Lee, S. J., Sanchez-Watts, G., Krieger, J.-P., Pignalosa, A., Norell, P. N., Cortella, A., Pettersen, K. G., Vrdoljak, D., Hayes, M. R., Kanoski, S. E., et al. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.03.008 · Cited by 95
Cheng, W., Ndoka, E., Hutch, C., Roelofs, K., MacKinnon, A., Khoury, B., Magrisso, J., Kim, K. S., Rhodes, C. J., Olson, D. P., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.134359 · Cited by 97
Self-citationDong, Y., Carty, J., Goldstein, N., He, Z., Hwang, E., Chau, D., Wallace, B., Kabahizi, A., Lieu, L., Peng, Y., et al. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101352 · Cited by 93
Reappraising the role of the vagus nerve in GLP-1-mediated regulation of eating
Brierley, D. I., & de Lartigue, G. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15603 · Cited by 92
Dissecting the Physiology and Pathophysiology of Glucagon-Like Peptide-1
Paternoster, S., & Falasca, M. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00584 · Cited by 91
A novel mouse model of glucagon‐like peptide‐1 receptor expression: A look at the brain
Graham, D. L., Durai, H. H., Trammell, T. S., Noble, B. L., Mortlock, D. P., Galli, A., & Stanwood, G. D. (2020) · Journal of Comparative Neurology · doi:10.1002/cne.24905 · Cited by 88
Glucagon-Like Peptide-1 (GLP-1) in the Integration of Neural and Endocrine Responses to Stress
Diz-Chaves, Y., Herrera-Pérez, S., González-Matías, L. C., Lamas, J. A., & Mallo, F. (2020) · Nutrients · doi:10.3390/nu12113304 · Cited by 84
The Ascending GLP-1 Road From Clinical Safety to Reduction of Cardiovascular Complications
Drucker, D. J. (2018) · Diabetes · doi:10.2337/dbi18-0008 · Cited by 78
Self-citationHuang, Z., Liu, L., Zhang, J., Conde, K., Phansalkar, J., Li, Z., Yao, L., Xu, Z., Wang, W., Zhou, J., et al. (2022) · Science Advances · doi:10.1126/sciadv.abn5345 · Cited by 78
“Habener, Glucagonlike peptide I (7-37) actions on endocrine pancreas.”
BackgroundInfluentialSelf-citationAppetite- and Weight-Regulating Neuroendocrine Circuitry in Hypothalamic Obesity
Gan, H.-W., Cerbone, M., & Dattani, M. T. (2024) · Endocrine Reviews · doi:10.1210/endrev/bnad033 · Cited by 65
Hypothalamic mTORC2 is essential for metabolic health and longevity
Chellappa, K., Brinkman, J. A., Mukherjee, S., Morrison, M., Alotaibi, M. I., Carbajal, K. A., Alhadeff, A. L., Perron, I. J., Yao, R., Purdy, C. S., et al. (2019) · Aging Cell · doi:10.1111/acel.13014 · Cited by 62
GLP-1 action in the mouse bed nucleus of the stria terminalis
Williams, D. L., Lilly, N. A., Edwards, I. J., Yao, P., Richards, J. E., & Trapp, S. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.12.007 · Cited by 54
Gutgesell, R. M., Khalil, A., Liśkiewicz, A., Maity‐Kumar, G., Novikoff, A., Grandl, G., Liśkiewicz, D., Coupland, C., Karaoglu, E., Akindehin, S., et al. (2025) · Nature Metabolism · doi:10.1038/s42255-025-01294-x · Cited by 62
Oleoylethanolamide: A fat ally in the fight against obesity
Brown, J. D., Azari, E. K., & Ayala, J. E. (2017) · Physiology & Behavior · doi:10.1016/j.physbeh.2017.02.034 · Cited by 62
Self-citationInsulin Resistance in Osteoarthritis: Similar Mechanisms to Type 2 Diabetes Mellitus
Tchetina, E. V., Markova, G. A., & Sharapova, E. P. (2020) · Journal of Nutrition and Metabolism · doi:10.1155/2020/4143802 · Cited by 62
Tirzepatide suppresses palatable food intake by selectively reducing preference for fat in rodents
Geisler, C. E., Antonellis, M. P., Trumbauer, W., Martin, J. A., Coskun, T., Samms, R. J., & Hayes, M. R. (2023) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14843 · Cited by 51
Combined Amylin/GLP-1 pharmacotherapy to promote and sustain long-lasting weight loss
Liberini, C. G., Koch-Laskowski, K., Shaulson, E., McGrath, L. E., Lipsky, R. K., Lhamo, R., Ghidewon, M., Ling, T., Stein, L. M., & Hayes, M. R. (2019) · Scientific Reports · doi:10.1038/s41598-019-44591-8 · Cited by 50
Glucagon, GLP-1 and Thermogenesis
González-García, I., Milbank, E., Diéguez, C., López, M., & Contreras, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20143445 · Cited by 49
“Furthermore, the vagotomy surgical procedure blocks the suppressive effects of intraperitoneal (IP) GLP-1 [55,56], suggesting a parasympathetic-nervous-system-dependent effect of GLP-1.”
BackgroundChen, Z., Deng, X., Shi, C., Jing, H., Tian, Y., Zhong, J., Chen, G., Xu, Y., Luo, Y., & Zhu, Y. (2024) · Journal of Clinical Investigation · doi:10.1172/jci178239 · Cited by 48
Burmeister, M. A., Brown, J. D., Ayala, J. E., Stoffers, D. A., Sandoval, D. A., Seeley, R. J., & Ayala, J. E. (2017) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00113.2017 · Cited by 48
Self-citationLe, T. D. V., Fathi, P. A., Watters, A. B., Ellis, B. J., Besing, G.-L. K., Bozadjieva-Kramer, N., Perez, M. B., Sullivan, A. I., Rose, J. P., Baggio, L. L., et al. (2023) · Molecular Metabolism · doi:10.1016/j.molmet.2023.101718 · Cited by 50
Self-citationHypothalamic neuropeptides and neurocircuitries in Prader Willi syndrome
Corrêa‐da‐Silva, F., Fliers, E., Swaab, D. F., & Yi, C. (2021) · Journal of Neuroendocrinology · doi:10.1111/jne.12994 · Cited by 42
Park, J. S., Kim, K. S., & Choi, H. J. (2025) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2025.0106 · Cited by 58
A critical update on the l eptin‐melanocortin system
Lavoie, O., Michael, N. J., & Caron, A. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15765 · Cited by 46
Ratner, C., He, Z., Grunddal, K. V., Skov, L. J., Hartmann, B., Zhang, F., Feuchtinger, A., Bjerregaard, A., Christoffersen, C., Tschöp, M. H., et al. (2019) · Diabetes · doi:10.2337/db18-1009 · Cited by 40
Glucagon‐Like Peptide‐1: Actions and Influence on Pancreatic Hormone Function
Davis, E., & Sandoval, D. A. (2020) · Comprehensive physiology · doi:10.1002/cphy.c190025 · Cited by 59
Self-citationEffects of metabolic state on the regulation of melanocortin circuits
Lieu, L., Chau, D., Afrin, S., Dong, Y., Alhadeff, A. L., Betley, J. N., & Williams, K. W. (2020) · Physiology & Behavior · doi:10.1016/j.physbeh.2020.113039 · Cited by 37
Sloop, K. W., Briere, D. A., Emmerson, P. J., & Willard, F. S. (2018) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.8b00009 · Cited by 31
The diverse effects of brain glucagon‐like peptide 1 receptors on ingestive behaviour
Williams, D. L. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15535 · Cited by 34
Mulvihill, E. E. (2018) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000495 · Cited by 29
Intestinal Gpr17 deficiency improves glucose metabolism by promoting GLP-1 secretion
Yan, S., Conley, J. M., Reilly, A. M., Stull, N. D., Abhyankar, S. D., Ericsson, A. C., Kono, T., Molosh, A. I., Kubal, C. A., Evans‐Molina, C., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2021.110179 · Cited by 28
Zeng, N., Cutts, E. J., Lopez, C. B., Kaur, S., Duran, M., VIRKUS, S., & Hardaway, J. A. (2021) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2021.724030 · Cited by 26
Seeking satiety: From signals to solutions
Tschöp, M. H., & Friedman, J. M. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.adh4453 · Cited by 30
Metabolic factors in the regulation of hypothalamic innate immune responses in obesity
Folick, A., Cheang, R. T., Valdearcos, M., & Koliwad, S. K. (2022) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00666-z · Cited by 28
The interplay between leptin, glucocorticoids, and GLP1 regulates food intake and feeding behaviour
Perez‐Leighton, C. E., Kerr, B., Scherer, P. E., Baudrand, R. F., & Cortés, V. (2023) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.13039 · Cited by 27
GLP-1 physiology and pharmacology along the gut-brain axis
Beutler, L. R. (2026) · Journal of Clinical Investigation · doi:10.1172/jci194744 · Cited by 35
Dietary Fiber, Gut Microbiota, Short-Chain Fatty Acids, and Host Metabolism
Hou, L., Yang, Y., Sun, B., Jing, Y., & Deng, W. (2021) · American Journal of Life Sciences · doi:10.11648/j.ajls.20210906.12 · Cited by 29
Physiology of Energy Intake in the Weight‐Reduced State
Berthoud, H., Seeley, R. J., & Roberts, S. B. (2021) · Obesity · doi:10.1002/oby.23080 · Cited by 25
Self-citationNovel Co-Treatment Strategies to Attenuate Acute Olanzapine-Induced Metabolic Dysfunction
Medak, K. D. (2023) · The Atrium (University of Guelph) · doi:10.1152/ajpendo.00309.2020
State-dependent central synaptic regulation by GLP-1 is essential for energy homeostasis
Wang, L., Savani, R. H., Lu, Y., Bernabucci, M., Luis-Islas, J., Park, E., Singh, I., Xu, W., Ouaamari, A. E., Wheeler, M. B., et al. (2025) · Nature Metabolism · doi:10.1038/s42255-025-01305-x · Cited by 23
Neural pathways of nausea and roles in energy balance
Zhang, C. (2025) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2024.102963 · Cited by 20
Park, J.-W., Park, S. E., Koh, W., Jang, W. H., Choi, J. H., Roh, E., Kang, G. M., Kim, S. J., Lim, H. S., Park, C. B., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-46009-0 · Cited by 17
Brown, J. D., McAnally, D., Ayala, J. E., Burmeister, M. A., Morfa, C. J., Smith, L. H., & Ayala, J. E. (2018) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00459.2017 · Cited by 20
Self-citationKrieger, J.-P., Langhans, W., & Lee, S. J. (2018) · Physiology & Behavior · doi:10.1016/j.physbeh.2018.03.037 · Cited by 17
Crosstalk between alcohol use disorder and obesity: two sides of the same coin?
Leggio, L., Farokhnia, M., Kenny, P. J., Pepino, M. Y., & Simmons, W. K. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03259-8 · Cited by 18
Poly-Agonist Pharmacotherapies for Metabolic Diseases: Hopes and New Challenges
Allard, C., Cota, D., & Quarta, C. (2023) · Drugs · doi:10.1007/s40265-023-01982-6 · Cited by 17
Qi, R., Liang, Y., Yu, J., Chen, B., Jiang, J., Wu, X., Lu, W., & Li, Z. (2024) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-024-01202-0 · Cited by 18
Beyond satiety: unraveling the complex roles of POMC neurons in behavior and metabolism
Jouque, V., Miralpeix, C., López-Gambero, A. J., Nicolas, J. C., Quarta, C., & Cota, D. (2025) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-025-09993-2 · Cited by 19
Integration of Glucagon-Like Peptide 1 Receptor Actions Through the Central Amygdala
Duran, M., Willis, J. R., Dalvi, N., Fokakis, Z. N., VIRKUS, S., & Hardaway, J. A. (2025) · Endocrinology · doi:10.1210/endocr/bqaf019 · Cited by 13
Ceron, E. L., Reddy, S. D., Kattamuri, L. P. V., Muvva, D. M., Chozet, L. E., & Bright, T. M. (2025) · Journal of Brown Hospital Medicine · doi:10.56305/001c.132255 · Cited by 20
Incretin receptor agonism rapidly inhibits AgRP neurons to suppress food intake in mice
McMorrow, H. E., Cohen, A. B., Lorch, C. M., Hayes, N. W., Fleps, S. W., Frydman, J. A., Xia, J. L., Samms, R. J., & Beutler, L. R. (2025) · Journal of Clinical Investigation · doi:10.1172/jci186652 · Cited by 12
“While hypothalamic or hindbrain knockdown of GLP-1R reduces liraglutide efficacy, no brain region has been shown to be solely responsible for GLP-1R agonist-induced food intake suppression (21, 50–52).”
Glucagon‐Like Peptide‐1 Links Ingestion, Homeostasis, and the Heart
Krieger, J., Daniels, D., Lee, S. J., Mastitskaya, S., & Langhans, W. (2024) · Comprehensive physiology · doi:10.1002/cph4.7 · Cited by 15
Glucagon-Like Peptide 1 (GLP-1) Action on Hypothalamic Feeding Circuits
Hwang, E., Portillo, B., & Williams, K. W. (2025) · Endocrinology · doi:10.1210/endocr/bqaf125 · Cited by 10
Incretin hormones and pharmacomimetics rapidly inhibit AgRP neuron activity to suppress appetitePreprint
McMorrow, H. E., Lorch, C. M., Hayes, N. W., Fleps, S. W., Frydman, J. A., Xia, J. L., Samms, R. J., & Beutler, L. R. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.03.18.585583 · Cited by 10
Novel neural pathways targeted by GLP-1R agonists and bariatric surgery
Hankir, M. K., & Lutz, T. A. (2024) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-024-03047-3 · Cited by 16
Repurposing metabolic drugs as anti-inflammatory agents
Hogan, A. E., Davis, C., Jenkins, B. J., Jones, N., & O'Shea, D. B. (2025) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2025.07.003 · Cited by 15
Gut Peptide Agonism in the Treatment of Obesity and Diabetes
Grandl, G., Novikoff, A., DiMarchi, R. D., Tschöp, M. H., & Müller, T. D. (2019) · Comprehensive physiology · doi:10.1002/cphy.c180044 · Cited by 11
Hunting for heroes: Brain neurons mediating GLP-1R agonists in obesity treatment
Cao, Y., & Tong, Q. (2024) · Obesity Medicine · doi:10.1016/j.obmed.2024.100569 · Cited by 10
Obesity: assessment and treatment across the care continuum
Kushner, R. F., & Marla Shapiro, C. M. (2025) · Annals of Medicine · doi:10.1080/07853890.2025.2521433 · Cited by 14
Neuroendocrine Control of Body Energy Homeostasis
Affinati, A. H., & Myers, M. G. (2021) · Europe PMC (PubMed Central) · Cited by 16
Fradj, S. B., Nédélec, E., Salvi, J., Fouesnard, M., Huillet, M., Pallot, G., Cansell, C., Sanchez, C., Philippe, C., Gigot, V., et al. (2022) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0095 · Cited by 10
Sayers, S., & Wagner, E. J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26083897 · Cited by 9
Insights into the neurobiology of weight loss after bariatric surgery and GLP-1R agonists
Cook, T. M., Fuller, K. N. Z., & Sandoval, D. A. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.110269 · Cited by 7
Self-citationMattar, P., Jaque, C., Teske, J. A., Morselli, E., Kerr, B., Cortés, V., Baudrand, R. F., & Perez‐Leighton, C. E. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1164047 · Cited by 7
McEwen, H. J. L., Cognard, E., Ladyman, S. R., Aung, Z. K., Tups, A., Shepherd, P. R., & Grattan, D. R. (2018) · Journal of Neuroendocrinology · doi:10.1111/jne.12607 · Cited by 7
Chai-udom, R., Aroonparkmongkol, S., & Sahakitrungruang, T. (2018) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2017-0350 · Cited by 6
Savani, R. H., Park, E., Busannagari, N., Lu, Y., Kwon, H., Wang, L., & Pang, Z. P. (2024) · Bioscience Reports · doi:10.1042/bsr20231846 · Cited by 11
Metadata
- Authors
- Burmeister, M. A., Ayala, J. E., Smouse, H., Landivar-Rocha, A., Brown, J. D., Drucker, D. J., Stoffers, D. A., Sandoval, D. A., Seeley, R. J., & Ayala, J. E.
- Affiliations
- Sanford Burnham Prebys Medical Discovery Institute (US)
- Mount Sinai Hospital (CA)
- University of Pennsylvania (US)
- Michigan Medicine (US)
- Corresponding author
- Burmeister, Melissa A.
- ORCID
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2016-12-01
- Volume
- 66
- Issue
- 2
- Pages
- 372-384
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC5248999
- OpenAlex
- W2557682509
- Cited by
- 136
- References
- 51
- Citations by year
- 2026: 9 · 2025: 19 · 2024: 13 · 2023: 13 · 2022: 15 · 2021: 10 · 2020: 16 · 2019: 14 · 2018: 20 · 2017: 7
- FWCI
- 8.69
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Diabetes (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Canadian Institutes of Health Research (123391)
- National Institutes of Health (7R01DK082480, 1R01DK107652, 4R01DK097361)
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Keywords
- GLP-1 receptor, hypothalamus, energy balance, glucose homeostasis, paraventricular nucleus, proopiomelanocortin neurons, exendin-4, liraglutide, GLP-1 receptor agonists, dietary intake, energy expenditure, high-fat diet, weight loss, glucose tolerance
- MeSH terms
- Glucagon-Like Peptide-1 Receptor, Liraglutide, Exenatide, Animals, Body Composition, Eating, Energy Metabolism, Glucose, Glucose Tolerance Test, Homeostasis, Hypothalamus, Male, Neurons, Paraventricular Hypothalamic Nucleus, Peptides, Pro-Opiomelanocortin, Venoms, Weight Gain, Mice, Glucagon-Like Peptide 1, Incretins, Gene Knockdown Techniques, Diet, High-Fat
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.